Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis-Reference-Cited by-同舟云学术

Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis

Published:2018-04-17 Issue:6 Volume:45 Page:701-709
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Nakagawa Hidemi¹,Nemoto Osamu²,Yamada Hiroyuki³^ORCID,Nagata Takeshi³,Ninomiya Noriko³

Affiliation:

1. Department of Dermatology; The Jikei University School of Medicine; Tokyo Japan

2. Kojinkai Sapporo Skin Clinic; Hokkaido Japan

3. Clinical Development Department; Pharmaceutical Division; Japan Tobacco Inc.; Tokyo Japan

Funder

Japan Tobacco Inc.

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.14322/fullpdf

Reference14 articles.

1. Atopic dermatitis;Bieber;N Engl J Med,2008

2. Clinical practice guidelines for the management of atopic dermatitis 2016;Saeki;J Dermatol,2016

3. The burden of atopic dermatitis: impact on the patient, family, and society;Carroll;Pediatr Dermatol,2005

4. Clinical guidance for treatment of patients with atopic dermatitis by tacrolimus ointment 0.1% and 0.03%;Japanese FK 506 Ointment Study Group;Jpn J Clin Dermatol,2003

5. JAK and STAT signaling molecules in immunoregulation and immunemediated disease;O'Shea;Immunity,2012

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting immunotherapeutic strategies for the management of atopic dermatitis;Exploration of Asthma & Allergy;2024-08-09

2. Topical anti-inflammatory treatments for eczema: network meta-analysis;Cochrane Database of Systematic Reviews;2024-08-06

3. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials;Journal of Allergy and Clinical Immunology;2023-12

4. A review of biological agents and small molecules in the management of atopic dermatitis;Indian Journal of Skin Allergy;2023-10-27

5. Green HPTLC - Densitometric approach for quantitation of Ruxolitinib in bulk and marketed formulation;Research Journal of Pharmacy and Technology;2023-09-30